C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2002
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	EP1263800A1 A new linker based solid support for peptide and small molecule organic synthesis
12/11/2002	EP1263778A1 Peptide inhibitors of lfa-1/icam-1 interaction
12/11/2002	EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells
12/11/2002	EP1263775A1 Hla binding peptides and their uses
12/11/2002	EP1263473A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
12/11/2002	EP1263471A2 Antimicrobial compounds and formulations
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263455A2 Uses of bombesin receptor 3
12/11/2002	EP1140986B1 Pseudopeptide, synthesis method, reagent and applications
12/11/2002	EP0788511B1 Cyclic hexapeptides having antibiotic activity
12/11/2002	EP0591431B1 Hepatitis c virus (hcv) polypeptides
12/10/2002	US6492491 Method of making hypusine peptides
12/10/2002	US6492489 Synthetic hypusine peptides
12/10/2002	US6492460 Polystyrene solid support
12/10/2002	US6492330 Antiangiogenic drugs
12/10/2002	US6492328 Activity against gram-negative bacteria
12/10/2002	US6492105 Binding molecules for human factor VIII and factor VIII-like proteins
12/10/2002	US6491920 Polypeptides and DNA encoding same
12/10/2002	US6491871 System for determining receptor-ligand binding affinity
12/10/2002	CA2142240C A process for the preparation of cyclosporin a from tolypocladium species
12/10/2002	CA2121147C Synthetic lung surfactant having antioxidant properties
12/05/2002	WO2002097134A2 Modified peptide nucleic acid
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097037A2 Melanin-concentrating hormone analogs
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096936A2 Daptomycin and related analogs in crystalline form, their preparation and use
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096360A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	WO2002096350A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	WO2002070018A3 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/05/2002	WO2002042321A3 Mixed fibrils
12/05/2002	WO2001098362A3 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183256 Cytostatic-integrin conjugates having specifically cleavable linking units
12/05/2002	US20020183252 To inhibit tumor growth in an animal; to induce apoptosis
12/05/2002	US20020183242 Peptide antiangiogenic drugs
12/05/2002	US20020182218 Therapeutic anti-melanoma compounds
12/05/2002	US20020182215 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini.
12/05/2002	CA2665748A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	CA2449004A1 Melanin-concentrating hormone analogs
12/05/2002	CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/05/2002	CA2448171A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	CA2432187A1 Daptomycin and related analogs in crystalline form
12/04/2002	EP1262556A2 Antimicrobial peptides and method for identifying and using such peptides
12/04/2002	EP1261631A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
12/04/2002	EP1261626A1 Bombesin analogs for treatment of cancer
12/04/2002	EP1261625A2 Memno peptides, a process for their preparation and their use
12/04/2002	EP1261621A2 Phosphorylation assays
12/04/2002	EP1261369A2 Compositions and methods for tumor-targeted delivery of effector molecules
12/04/2002	EP1261362A2 Novel amino acid and peptide inhibitors of staphylococcus virulence
12/04/2002	EP1261360A1 Casein derived peptides and uses thereof in therapy
12/04/2002	EP1212352A4 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0638092B1 Synthetic peptide vaccines for dental caries
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/03/2002	US6489440 Aerothricins for the preparation of medicaments with antifunal properties
12/03/2002	US6489298 Contulakin-G, analogs thereof and uses thereof
12/03/2002	US6488929 Candida albicans phosphomannan complex as a vaccine
12/03/2002	CA2254853C Compositions and methods for screening antimicrobials
12/03/2002	CA2116120C Peptides having growth hormone releasing activity
12/03/2002	CA2073856C Glp-1 analogs useful for diabetes treatment
11/2002
11/30/2002	CA2387406A1 Protein kinase peptide substrate determination using peptide libraries
11/28/2002	WO2002095043A1 Cellular signal-responsive gene transcriptional regulation system
11/28/2002	WO2002095027A2 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094985A2 Beta-secretase substrates and uses thereof
11/28/2002	WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094845A2 Method for stabilising of nucleic acids
11/28/2002	WO2002094822A1 Uronium and immonium salts for peptide coupling
11/28/2002	WO2002094778A2 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
11/28/2002	WO2002094314A1 Tsg101 as inhibitor of hiv production
11/28/2002	WO2002094029A1 Method of inhibiting fungal growth
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002062969A3 Cellular reprogramming in peptide hydrogel and uses thereof
11/28/2002	WO2002061038A9 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
11/28/2002	WO2002054065A3 Reversible mhc multimer staining for functional purification of antigen-specific t cells
11/28/2002	WO2002047711A3 Modulators of activity of g-protein-coupled receptor kinases
11/28/2002	US20020177725 Peptide inhibitors of hepatitis C virus NS3 protein
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	US20020177573 Ligand for bacterial toxins, which is capable of selective interaction with the beta-sheet-hinge-alpha-helix structure of the superantigens.
11/28/2002	US20020177545 Compositions and methods for treating gonadotrophin related illnesses
11/28/2002	US20020177226 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants
11/28/2002	US20020177178 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/28/2002	US20020177177 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020176819 Gastrin receptor-avid peptide conjugates
11/28/2002	CA2448531A1 Uronium and immonium salts for peptide coupling
11/28/2002	CA2448142A1 Beta-secretase substrates and uses thereof
11/28/2002	CA2448031A1 Method for stabilising of nucleic acids
11/28/2002	CA2448014A1 Tsg101 as inhibitor of hiv production
11/28/2002	CA2447793A1 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/27/2002	EP1259591A2 Polypetptides and methods for thymic vaccination
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259536A2 Methods of peptide preparation
11/27/2002	EP1259535A1 Cyclic hexapeptide derivatives

1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 423